Development of novel monoclonal antibodies with specific binding affinity for denatured human CD26 in formalin-fixed paraffin-embedded and decalcified specimens

• Ryo Hatano,

  Roles Conceptualization, Funding acquisition, Investigation, Visualization, Writing – original draft

  Affiliation Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Hongo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Taketo Yamada,

  Roles Conceptualization, Funding acquisition, Investigation, Supervision, Visualization, Writing – review & editing

  Affiliations Department of Pathology, Saitama Medical University, Moroyama-machi, Iruma-gun, Saitama, Japan, Department of Pathology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan

  ⨯
• Hiroko Madokoro,

  Roles Investigation

  Affiliation Department of Pathology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan

  ⨯
• Haruna Otsuka,

  Roles Investigation

  Affiliation Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Hongo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Eriko Komiya,

  Roles Investigation

  Current address: Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Tomioka, Urayasu, Chiba, Japan.

  Affiliation Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Hongo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Takumi Itoh,

  Roles Investigation

  Affiliation Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Hongo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Yuka Narita,

  Roles Investigation

  Affiliation Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Hongo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Satoshi Iwata,

  Roles Writing – review & editing

  Affiliation Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Hongo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Hiroto Yamazaki,

  Roles Writing – review & editing

  Affiliation Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Hongo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Shuji Matsuoka,

  Roles Validation

  Affiliation Department of Immunological Diagnosis, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Nam H. Dang,

  Roles Writing – review & editing

  Affiliation Division of Hematology/Oncology, University of Florida, Gainesville, FL, United States of America

  ⨯
• Kei Ohnuma,

  Roles Funding acquisition, Supervision, Writing – review & editing

  Affiliation Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Hongo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Chikao Morimoto

  Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing

  * E-mail: morimoto@ims.u-tokyo.ac.jp

  Affiliation Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Hongo, Bunkyo-ku, Tokyo, Japan

  http://orcid.org/0000-0002-3140-3596

  ⨯